- Home
- LE vs SLDB Comparison
LE vs SLDB Comparison
Compare LE & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LE | SLDB |
|---|---|---|
| Founded | 1963 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.7M | 444.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | LE | SLDB |
|---|---|---|
| Price | $14.46 | $5.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $20.00 | $14.82 |
| AVG Volume (30 Days) | 205.3K | ★ 910.5K |
| Earning Date | 12-09-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $1,314,437,000.00 | N/A |
| Revenue This Year | $2.06 | N/A |
| Revenue Next Year | $2.44 | N/A |
| P/E Ratio | $38.68 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.65 | $2.41 |
| 52 Week High | $17.12 | $7.37 |
Technical Indicators
Market Signals| Indicator | LE | SLDB |
|---|---|---|
| Relative Strength Index (RSI) | 42.38 | 55.93 |
| Support Level | $14.00 | $5.68 |
| Resistance Level | $15.75 | $6.08 |
| Average True Range (ATR) | 0.75 | 0.37 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 30.65 | 63.21 |
Price Performance
Historical ComparisonAbout LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.